Exabis Library
Welcome to the e-CCO Library!
P449 Systematic review with meta-analysis: risk of lymphoma associated with anti-tumour necrosis factor (TNF) agents in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P449: Autologous fat graft injection for the treatment of perianal fistulas in Crohn’s disease: A systematic review and single-arm meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P449: Cost Effectiveness of a Proactive Therapeutic Drug Monitoring Strategy in Patients with Inflammatory Bowel Disease Receiving Infliximab
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P449: Double assessment of ileal pouch-anal anastomosis before ileostomy reversal
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P449: Efficacy and safety of switching between originator and biosimilar infliximab in patients with inflammatory bowel disease in practical clinic: results to 6 months
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P449: Minimally invasive IPAA in UC: Preliminary results from a referral center
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P449: Patient support program for adalimumab-treated patients with Crohn's disease in Brazil: impact on patients' adherence and persistence
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P449: Selective depletion of LAG3+ cells in T-cell-driven inflammation: a randomised, double-blind, placebo-controlled, FTIH phase I/Ib clinical trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P450 Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P450: A gender comparison of the association between coping strategies and perceived social support in Crohn’s disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P450: Association of Infliximab trough levels and transmural healing in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P450: Mind the gap: Why do physicians underestimate their patient's adherence?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P450: Real life Effectiveness and safety of an induction treatment with tofacitinib in patients with Ulcerative Colitis: First results of the French TOFAST cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P450: Reliability assessment of endoscopic scoring tools using central video review of colonoscopies in paediatric patients with ulcerative colitis: data from the Canadian Children IBD Network
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P450: Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P450: Vaccination strategies in Inflammatory Bowel Disease patients: perspective of physicians and patients.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P451 Short-and long-term effectiveness of ustekinumab in patients with Crohn’s disease: real-world data from a German IBD cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P451: Compound IBD patient profiles are related to specific information needs – an Israeli national survey
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P451: Early infliximab trough levels in paediatric IBD patients predict sustained remission
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P451: Efficacy and safety of tofacitinib in the treatment of patients with active, moderate to severe, Ulcerative Colitis: a systematic review and meta-analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM